Stay updated with breaking news from Broad Second Generation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Issuer: CureVac / Key word(s): Quarter Results25.05.2022 / 13:05 The issuer is solely responsible for the content of this announcement.CureVac Announces Financial Results for the First Quarter of 2022 and Provides Business Update Progressing broad vaccine development program in collaboration with GSK, with second-g...
DGAP-News: CureVac Announces Financial Results for the First Quarter of 2022 and Provides Business Update
Investegate announcements from CureVac, CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2021 and Provides Business Update
Issuer: CureVac / Key word(s): Quarter Results CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2021 and Pro...
- Executing on broad vaccine development program, with new clinical studies in COVID-19 and influenza together with GSK to validate advanced second-generation mRNA backbone- Initiated Phase 1 dose-escalation